MENU
ELOX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Eloxx Pharmaceuticals (ELOX) Ownership - Who owns Eloxx Pharmaceuticals?

Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in developing novel, small-molecule product candidates designed to modulate the ribosome and promote readthrough of premature stop codons induced by nonsense mutations (NMs) to enable the production of full-length proteins... Show more

Industry: #Biotechnology

Profile

Industry
Biotechnology
Address
10 Court Street
Phone
+1 781 577-5300
Employees
10
Web
https://www.eloxxpharma.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
54.02M
P/E Ratio
4.47
Total Cash
61.96M
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
-1393.04
Dividend Yield
N/A
Total Cash/Share
18.03
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
ELOX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of novel therapeutics and drugs

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
10 Court Street
Phone
+1 781 577-5300
Employees
10
Web
https://www.eloxxpharma.com
Who owns Eloxx Pharmaceuticals? ELOX symbol Ownership - Tickeron.com